FDA Approves New Oral Antibiotic for Complex Urinary Tract Infections

The U.S. FDA has granted approval for tebipenem pivoxil, the first oral carbapenem antibiotic, to treat complicated UTIs in adults. This new medication offers an alternative to intravenous therapy, potentially allowing for more outpatient management of drug-resistant infections. It represents a significant development for patients with limited treatment options.